Adaptive Protein Corona Nanoassemblies Couple Cytokine Signaling with Endogenous Antigen Transport for Systemic Cancer Immunity
- 22 June 2026
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (26) , 27372-27388
Abstract
Protein corona formation is widely viewed as an inevitable but poorly controlled event when nanoparticles encounter biological environments. Converting this interfacial layer into a programmable functional entityremains a major challenge. Here, we report an adaptive protein corona nanoassembly strategy that integrates cytokine signaling with endogenous antigen transport. Coordination-engineered manganese nanoscaffolds were assembled with interleukin-12 (IL-12) and protected by an enzyme-responsive hyaluronic acid shell to form nanoshuttles (NSs) capable of dynamic protein recruitment in the tumor microenvironment (TME). Following enzymatic activation, exposure of the cationic manganese surface promotes adaptive corona formation and efficient capture of tumor-derived antigens. The resulting antigen-associated nanoassemblies traffic to tumor-draining lymph nodes, where they facilitate dendritic cell cross-presentation and tumor-specific T-cell priming. This coordinated process couples intratumoral cytokine signaling with antigen delivery, generating potent systemic antitumor immunity at significantly reduced IL-12 doses. These findings establish adaptive protein corona nanoassembly as a chemical strategy for programming nano–bio interfaces to coordinate cytokine signaling and antigen transport.Keywords
Funding Information
- Chinese Academy of Sciences (XDB1030000)
- National Key Research and Development Program of China (2021YFA1200900)
- National Key Research and Development Program of China (2022YFA1603701)
- National Key Research and Development Program of China (2024YFA1509603)
- National Key Research and Development Program of China (2024YFC2310503)
- National Natural Science Foundation of China (22388101)
- National Natural Science Foundation of China (22422403)
- National Natural Science Foundation of China (U25A20655)
- Noncommunicable Chronic Diseases-National Science and Technology (2025ZD0549100)
This publication has 42 references indexed in Scilit:
- Dual‐Cascade Responsive Nanoparticles Enhance Pancreatic Cancer Therapy by Eliminating Tumor‐Resident Intracellular BacteriaAdvanced Materials, 2022
- Advances in the biological mechanism and application of manganese-based nanoformulations for enhanced immunotherapyNano Today, 2022
- Novel strategies exploiting interleukin-12 in cancer immunotherapyPharmacology & Therapeutics, 2022
- Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirusNano Today, 2021
- Tumor‐Associated Macrophage and Tumor‐Cell Dually Transfecting Polyplexes for Efficient Interleukin‐12 Cancer Gene TherapyAdvanced Materials, 2020
- Cancer Cell Coating Nanoparticles for Optimal Tumor-Specific Cytokine DeliveryACS Nano, 2020
- Memory T cells: strategies for optimizing tumor immunotherapyProtein & Cell, 2020
- The Nano–Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox ReactionsAccounts of Chemical Research, 2019
- Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA VirusesImmunity, 2018
- Interleukin 12: still a promising candidate for tumor immunotherapy?Cancer Immunology, Immunotherapy, 2014